Latham & Watkins represented Con Edison in the transaction. Freshfields Bruckhaus Deringer provided comprehensive advice to RWE AG. Consolidated Edison, Inc. (Con Edison) (NYSE: ED), one of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Viasat in the transaction while Morrison Foerster served as government contracts and regulatory counsel to L3Harris on regulatory matters. Viasat Inc. (NASDAQ: VSAT),...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Centricus in the transaction. Centricus, the London-based global investment firm, has acquired a majority stake in SK Global Entertainment, a leading independent...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised an arranger group led by Credit Suisse in the transaction. The group of arrangers granted a senior secured credit facilities consisting of a...
You must be a Standard 1 Year member to access this content.
Latham successfully defended U.S. Sugar against the U.S. Department of Justice Antitrust Division (DOJ) challenge to the Florida company’s acquisition of Imperial Sugar Co. Filed in...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Worthington Industries in the transaction. Worthington Industries, Inc. (NYSE: WOR), a leading industrial manufacturing company, has announced that its Board of Directors unanimously...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised TASKING on the deal. TASKING, a leading provider of embedded software development tools, executed the acquisition of iSYSTEM. The transaction is subject...
You must be a Standard 1 Year member to access this content.
Milbank and Latham & Watkins advised funds advised by Bregal Unternehmerkapital on the deal. Bregal Unternehmerkapital (“BU”) announced the financing of the acquisition of a majority stake...
You must be a Standard 1 Year member to access this content.
Walder Wyss, Stephenson Harwood, Proskauer Rose, Mourant Ozannes, Arendt & Medernach, Latham & Watkins, Stephenson Harwood, Gleiss Lutz and Poellath advised DPE on this transaction. Debevoise...
You must be a Standard 1 Year member to access this content.
Davis Polk advised BTRS Holdings on the deal, while Weil, Gotshal & Manges represented EQT. Latham & Watkins advised the financing sources for the transaction. BTRS...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Octagon Therapeutics in the transaction. Octagon Therapeutics, a preclinical-stage biopharmaceutical company developing targeted medicines for autoimmune disease, has announced the initiation of a...
You must be a Standard 1 Year member to access this content.
